000919.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 07:26):

Stats
Dzisiejszy wolumen	3.90M
Średni wolumen	7.32M
Kapitalizacja rynkowa	4.21B
EPS	CNY0.0399 ( 2023-09-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	30.77
ATR14	CNY0.0110 (0.16%)

Wolumen Korelacja

Długi: 0.00 (neutral)

Krótki: 0.65 (weak)

Signal:(42.317) Neutral

Jinling Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jinling Pharmaceutical Korelacja - Waluta/Towar

0.89
( strong )

0.90
( strong )

0.00
( neutral )

0.89
( strong )

0.00
( neutral )

-0.86
( strong negative )

Jinling Pharmaceutical Finanse

Annual	2022
Przychody:	CNY2.67B
Zysk brutto:	CNY528.14M (19.77 %)
EPS:	CNY0.210

FY	2022
Przychody:	CNY2.67B
Zysk brutto:	CNY528.14M (19.77 %)
EPS:	CNY0.210

FY	2021
Przychody:	CNY2.81B
Zysk brutto:	CNY630.07M (22.43 %)
EPS:	CNY0.240

FY	2020
Przychody:	CNY2.50B
Zysk brutto:	CNY561.39M (22.42 %)
EPS:	CNY0.129

Financial Reports:

No articles found.

Jinling Pharmaceutical

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China. The company offers Mailuoning injection for the treatment of thrombo-occlusive vasculitis, arteriosclerotic occlusive disease, cerebral thrombosis and sequelae, multiple arteritis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; and lentinan injection for treatment of malignant tumors. It also provides medical health care services. Jinling Pharmaceutical Company Limited is based in Nanjing, China.